Israeli cannabis firm Kanabo to be bought by London’s Spinnaker



Israeli cannabis firm Kanabo to be bought by London’s Spinnaker


(Reuters) – Israel’s Kanabo Research has agreed to be bought by cash shell Spinnaker Opportunities (SOP.L), in what could lead to the first listing of a cannabis company on London’s main stock market.

In a statement on Monday, Spinnaker did not disclose the value of the proposed reverse takeover, which would allow Tel Aviv-based Kanabo to bypass traditional listing rules.

The companies did not immediately respond to requests for comment on the value.


Spinnaker has also agreed to pump in 200,000 pounds ($256,600.00) into Kanabo, which is looking to grow sales. The Israeli company already has a promise of 1.4 million pounds from the London-listed firm.


Kanabo supplies medical cannabis products that do not contain THC, the psychoactive ingredient in marijuana which causes hallucinations. Its products are delivered through a vaping device.

The London Stock Exchange has not seen many pot firms in its indexes. GW Pharmaceuticals (GWPH.O), which makes marijuana-based epilepsy treatments, was listed on the bourse’s junior market between 2001 and 2016.



Leave a comment


Your message has been successfully sent.
Oops! Something went wrong.

Get in touch

If you wish to enquire about anything, or just say hi, please fill in the form opposite, or email us on: